Implicity Releases SMART on FHIR App New feature tackles atrial fibrillation burden, reducing the alerts for patients being treated with anticoagulant medication and highlighting clinically significant events. Cambridge, Mass., April 12, 2023 – Implicity, a leader in remote patient monitoring and cardiac data management solutions, introduced a new algorithm designed to reduce alert fatigue in the remote monitoring of patients with atrial fibrillation (AF). Implicity’s AF Alert Management feature addresses AF burden, reducing alerts for patients who are taking anticoagulants and have a low risk of complications while triggering notifications the relevant moment there is a significant change in a patient’s condition that requires intervention or adjustments to treatment. “The AF Alert Management tool optimizes AFib burden management, allowing providers to focus on clinically significant events,” said Adélie Cerrato, Product Manager at Implicity. “AFib burden can vary greatly between individuals on anticoagulants or those who are not. Our new algorithm can differentiate between the two, quieting alerts associated with patients on medication and notifying providers with smart alerts when the burden exceeds the threshold for action. This, in turn, can lead to better patient outcomes as they receive appropriate care when needed.” Continuous remote monitoring is critical for properly managing patients with AF. It allows providers to track patients’ heart rhythms for early intervention and treatment, reducing complications such as stroke and heart failure. The AF burden rate, or percentage of time spent in an irregular heartbeat state, is measured using various devices, such as Holter monitors, pacemakers, defibrillators, and implantable loop recorders (ILRs). Implicity’s algorithm works with any device that collects atrial burden trends data and can classify the following scenarios in line with ESC recommendations: Consider proposing therapies to the patient, such as ablation: Paroxysmal AF Increasing paroxysmal AF Persistent AF Evaluates the success of therapies: Back to sinus rhythm Back to paroxysmal AF On average, cardiologists receive about 1,000 manufacturer’s alerts on atrial burden/month per every 1,000 patients. Reviewing these alerts manually can prove to be time-consuming and inefficient. Implicity’s AF Alert Management alleviates this pain point and has the potential to save hours of time each month, freeing up clinicians so they can focus on patient care. About ImplicityImplicity is a MedTech software company dedicated to providing the best remote care to patients with connected cardiac implantable electronic devices. Co-founded by cardiac electrophysiologist Arnaud Rosier, MD, our platform aggregates, normalizes, and standardizes data from any implantable cardiac device across all manufacturers, improving care for those with chronic heart failure conditions. As the first and only cardiac implant remote monitoring company to receive FDA clearance for an AI-based algorithm, Implicity’s platform provides critical health information, enabling healthcare providers to make more informed decisions for better patient outcomes. With access to the Health Data Hub*, one of the world’s largest databases of heart disease patients, Implicity is able to develop its AI solutions based on more robust data. The company is protecting more than 80,000 patients in over 150 medical facilities across the US and Europe. To learn more, visit www.implicity.com * Health Data Hub is a health data platform established by the French government to combine existing health patient databases and facilitate their usage for research and development purposes.

The Association of German Cardiologists BNK Lists the Telemonitoring System Offered by Implicity and HCSG The Association of German Cardiologists BNK Service GmbH lists the telemonitoring system “hedy” from HCSG and IMPLICITY to cardiologists in private practice. As a unique cloud-based and vendor-independent platform for heart failure telemonitoring, hedy enables telemonitoring with external devices and implants from all major manufacturers via a common TMZ portal. This listing by BNK Service GmbH was made after intensive testing and based on positive references from cardiologists who are already using the hedy telemonitoring system today. Since the beginning of 2022, telemonitoring patients with heart failure (cardiac insufficiency) has been part of the outpatient service offered by the statutory health insurance funds. “We want telemonitoring for heart failure to reach all patients eligible for this innovative treatment method as quickly as possible. That is why we are pleased to have gained HCSG and IMPLICITY, two very capable partners for cardiology practices.”Susanne Oldenburg of BNK Service GmbH. To implement telemonitoring, a cardiology-led telemedicine center (TMZ) must use either external devices (scales, ECG and blood pressure monitors, and patient apps) or data from implants (special pacemakers and defibrillators). For this purpose, hedy offers a unique cloud-based platform for telemonitoring of heart failure, via which the data of implants from all major manufacturers and external devices can be displayed and evaluated automatically and independently of the manufacturer via a common TMZ portal. Hedy requires no IT installation or maintenance of IT systems in the physicianˈs office. Physicians can access HCSGˈs certified tele-nurse center, relieving their practices of routine tasks. “Cardiologists need the support of competent service providers to operate a telemedicine center. The practices we interviewed reported their excellent experience, reliable service, and HCSGˈs profound expertise in monitoring with external devices. Implants from all major manufacturers can be connected via the IMPLICITY system. This provides cardiologists with a common portal for all forms of telemonitoring. We see this as a great advantage for patient care.”Simon Glück, Managing Director of BNK Service GmbH. BNK Service GmbH has intensively tested the technology and service offering around hedy. The consistently positive feedback from practices that operate a TMZ with hedy and have already gained sound experience in its use has convinced BNK Service GmbH. To date, around 350 physicians are using hedy telemonitoring. Users of hedy can be found in individual practices as well as in sizeable professional practice groups (joint practices) or medical care centers (MVZ). “We want to ensure that all heart failure patients receive optimal care. Even those who find it difficult to get to the doctor because they live in rural areas or, in particular, the elderly patients. With hedy and the companies HCSG and IMPLICITY at our side, the start for this is quite easy, and we canbenefit from their years of experience. The direct accessibility and service canˈt be beaten.”Dr. Placke specialist practice for cardiological primary and specialty care in Rostock, Germany. “We had already preferred the hedy telemonitoring system based on recommendations from colleagues. The presentation of experienced users of the hedy solution for external devices and implants in the BNK webinars strengthened our decision. And we are starting with hedy in the new year.”Dr. med. Gabelmann and Prof. Pottgießer, Cardiology Dreisamtal/Kirchzarten Background:Since the beginning of 2022, telemonitoring patients with heart failure (cardiac insufficiency) has been part of the outpatient service offered by the statutory health insurance funds. Telemonitoring can be prescribed to patients with heart failure (NYHA II – III and EF < 40) if they have been treated in the hospital in the last 12 months or if they wear a suitable implant.To implement telemonitoring, a telemedicine center (TMZ) must use either external devices (scales, ECG and blood pressure monitors, and patient apps) or implants (special pacemakers and defibrillators). Hedy (https://hedy.de) refers to a system for telemedicine care of patients with heart failure. The solution is aimed at cardiologists who want to operate their own TMZ. Hedy is a registered trademark of Health Care Systems GmbH. Cooperation partners:HCSG specializes in telemonitoring with external devices, while IMPLICITY processes the data of implants from all major manufacturers for cardiologists. With the complete solution from HCSG and IMPLICITY, consisting of devices, software, service, and consulting, cardiologists can immediately set up their own TMZ (https://www.IMPLICITY.com/landing-page/partnership-IMPLICITY-x-hcsg/). BNK Service GmbH (https://www.bnk-service.de/) is the subsidiary of the Bundesverband Niedergelassener Kardiologen (BNK) e.V., which represents more than 90 percent of the practicing cardiologists in Germany. BNK Service supports approximately 1,200 cardiologists in their daily practice. In addition, as a specialized service provider for the entire cardiology field, it networks all the players involved in care. As a central interface, BNK Service GmbH develops and manages comprehensive care concepts, conducts scientific surveys on care research, and thus provides a realistic picture of cardiological care in Germany.Your contact: Simon GlückPhone: +49 89 41 42 40 8-14, Email: simon.glueck@bnk-service.de IMPLICITY (https://implicity.com) is a digital medical technology company that provides healthcare providers with a universal telemonitoring platform that aggregates and uniformly displays implantable cardiac implant data from all major manufacturers. In addition, IMPLICITY develops AI and knowledge-based algorithms to empower physicians and enable them to predict patient health status. IMPLICITY serves over 80,000 patients in more than 150 medical facilities in Europe and the US.Your contact: Karsten HagemannPhone: +33 680 10 50 65, Email: karsten.hagemann@implicity.com Health Care Systems GmbH (https://hcsg.de) is a leading provider of solutions for digital precision medicine. The HCSG team has more than 16 years of experience in telemedicine care for patients with heart failure. Today, HCSG serves patients throughout Germany and Switzerland with more than 60 employees at three locations. HCSG has developed the hedy Telemonitoring Program (https://hedy.de) specifically for use in telemedicine centers. The system is particularly easy to use because it is tailored to the needs of older people with severe chronic illnesses. Specialized nurses staff HCSG’s service center with special training in telephone care for people with heart failure. Health data is processed in a high-security data center in Germany.Your contact: Christian KlossPhone: +49 89

Implicity to Participate in Health Tech Challengers Super Finals at the HLTH 2022 Company named a Top 8 Super Finalist in the global health tech competition identifying the most disruptive companies shaping the future of digital health. Cambridge, Mass., November 8, 2022 – Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced it has been selected to participate in the Health Tech Challengers (HTC) Super Finals taking place live at HLTH 2022. The global competition identifies top companies fostering digital health innovation. Implicity won the Cardiovascular track and is one of only eight startups invited to pitch in-person at the live event in Las Vegas on November 15, 2pm at Venetian Ballroom D, Lvl 2, where the ultimate winner will be announced. “We’re honored to be among such an impressive group of finalists. This recognition validates the positive impact our AI-powered platform is having on cardiologists and healthcare professionals who care for patients with CIEDs. These remote cardiac monitoring solutions are producing more and more data each year. The only way for clinicians to process it all is with artificial intelligence-based tools. We are proud to deliver a solution to the market that can improve day-to-day life for practitioners, and allow them to spend more time with their patients,” said Dr. Arnaud Rosier, electrophysiologist, CEO, and co-founder of Implicity. Implicity’s AI algorithm that analyzes ECG data from implantable loop recorders (ILRs) received clearance from the Food and Drug Administration in late 2021. Earlier this year, the company announced $23M in Series A funding to accelerate expansion in the US and support the development of next-generation offerings that move toward the prevention of heart disease. Health Tech Challenger finalists were selected by a distinguished panel of industry experts from leading corporations, Venture Capital, ecosystem builders, and media partners. For more on the competition, visit: ​​https://healthtechchallengers.com/#TOP8   About Implicity Implicity® is a MedTech software company, cofounded by cardiac electrophysiologist Arnaud Rosier MD, that provides a universal cardiac remote monitoring and research platform to clinics and service companies – helping them provide the best remote care to cardiac patients. Implicity develops unique AI and knowledge-based algorithms with the potential to predict patient health status, which reduce the workload on healthcare professionals. The Implicity platform aggregates, normalizes, and standardizes data from all implantable cardiac electronic devices across all major manufacturers and improves care for patients with chronic heart failure conditions. Implicity proudly protects more than 70,000 patients in 150+ medical facilities across the United States and Europe.     Media Contact: Samantha Choinski eMedia Junction  860-301-5058 samantha@emediajunction.com